NDC 50242-087

Kadcyla 20 mg per 1 mL injection, powder, lyophilized, for solution

On the label: Genentech, Inc..

Switzerland: 2

Where it's made

FactoryWhereRoleLast FDA inspection
F. Hoffmann-La Roche AGKaiseraugst, SwitzerlandMakes it, tests it, packages it and labels it Problems found, fixed voluntarilyMar 21, 2025 · 8 inspections
F. Hoffmann-La Roche AGBasel, SwitzerlandMakes the active ingredient and tests it Problems found, fixed voluntarilyMay 9, 2025 · 9 inspections
Genentech, Inc.South San Francisco, CA, United StatesTests it and labels it No problems foundMay 15, 2026 · 37 inspections
Genentech, Inc.Oceanside, CA, United StatesTests it No problems foundAug 16, 2024 · 5 inspections
Genentech, Inc.Hillsboro, OR, United StatesPackages it and labels it Problems found, fixed voluntarilyApr 19, 2024 · 7 inspections
Lonza Biologics Tuas Pte. Ltd.Singapore, SingaporeTests it Problems found, fixed voluntarilyJun 27, 2023 · 5 inspections
Roche Diagnostics GmbHMannheim, GermanyTests it Problems found, fixed voluntarilyOct 29, 2021 · 5 inspections
Roche Singapore Technical Operations Pte. Ltd.Singapore, SingaporeTests it Problems found, fixed voluntarilyNov 14, 2025 · 6 inspections

Product details

Generic drug
Trastuzumab Emtansine: every company that makes it
Form
injection, powder, lyophilized, for solution, intravenous
Strength
20 mg per 1 mL
Approval
BLA BLA125427
On the market since
Feb 22, 2013
Package NDCs
50242-087-01
Official label
DailyMed (National Library of Medicine), updated Apr 1, 2026

Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?